First reported from Wuhan, China, on 31 December 2019, 2019-nCoV is the cause of coronavirus disease 2019 (COVID-19) and generally spreads through human-to-human contact or respiratory droplet infection from coughs and sneezes and it is thought to have a zoonotic origin. The symptoms of COVID-19 include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In severe cases, it can lead to pneumonia, severe respiratory acute syndrome, kidney failure and even death. Due to its high contagiousness and severeness, rapid detection of the virus should be performed as quickly as possible for proper medication and treatment.

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. And since the SARS-CoV-2 has been spreading globally, variants of concern (VOCs), including the Delta and Omicron variants have emerged and spread in many countries around the world. Due to its high contagiousness and severeness, rapid detection of virus is being the key factor to prevent transmission of the disease.

In the post-COVID era, the world needs a rapid and accurate diagnosis solution of different respiratory viruses for the appropriate patient management. Currently, testing for respiratory viruses is increasingly dependent on molecular assays, such as PCR, which can provide highly sensitive and accurate results. Increasingly, multiplex PCR are being used for respiratory virus detection, enabling the simultaneous detection of all significant respiratory viral targets. SMARTCHEK^® SARS-CoV-2/Flu/RSV Detection Kit is a reverse transcription real-time polymerase chain reaction assay intended for diagnosis to respiratory infectious disease with GENECHECKER^® UF-300 and UF-340 Real-time PCR System.

Tuberculosis which is an infectious disease caused by tuberculosis bacteria, usually affects lungs, but can also affect other body organs, such as lymph nodes, kidney, peritoneum, intestine or even skin. According to announcement from WHO, an estimated 10 million people fell ill with tuberculosis and a 1.4 million people died from TB worldwide in 2019. Early diagnosis is one of the key factors for treatment of the disease due to its side effects and additional infections caused by misdiagnosis. As a result, development and applications of tuberculosis assays to assure its high sensitivity and accuracy are still actively ongoing throughout the world.

Human papillomavirus(HPV) is the cause of cervical cancer and is the most common sexually transmitted disease among women. Most people with HPV have no symptoms, so early diagnosis is one of the key factors for prevention of associated diseases. Currently, molecular diagnosis is the most sensitive and accurate method for detection of HPV. Increasingly, multiplex PCR is being used for HPV detection, enabling the simultaneous detection of significant HPV viral target genes. SMARTCHEK® HPV Detection Kit is a real-time polymerase chain reaction assay, intended for diagnosis to Human papillomavirus using GENECHECKER® UF-300 and UF-340 Real-time PCR System.

Sexually Transmitted Infection (STI) is a major public health problem that can lead to serious consequences including neurological and cardiovascular disease, infertility, and stillbirths. Most people with STI have no symptoms, so early diagnosis is one of the key factors to prevent transmission of the disease. Currently, molecular diagnosis is the most sensitive and accurate method for detection of sexually transmitted pathogens. Increasingly, multiplex PCR is being used for STI testing, enabling the simultaneous detection of significant sexually transmitted pathogens. SMARTCHEK® STI Test Kit is a real-time polymerase chain reaction assay, intended for diagnosis of sexually transmitted infection using GENECHECKER® UF-300 and UF-340 Real-time PCR System.

Multidrug-resistant tuberculosis(MDR-TB) is caused by mycobacterium tuberculosis that is resistant to at least isoniazid(INH) and rifampin(RIF), the first-line treatment for tuberculosis. Since second-line drugs for MDR-TB have more side effects and may result in extensively drug-resistant tuberculosis (XDR-TB), PCR testing for MDR-TB is necessary to detect resistance to these 2 major anti-tuberculosis drugs. SMARTCHEK^® MDR TB Detection Kit is a real-time polymerase chain reaction assay, intended for diagnosis of multidrug-resistant tuberculosis(MDR-TB) by detecting INH and RIF resistant TB at a single PCR run.

Mycobacterium tuberculosis (MTB) is the causative agent of tuberculosis (TB), a serious and potentially fatal disease that requires prompt and effective treatment. Nontuberculous mycobacteria (NTM), on the other hand, are mycobacteria that do not cause TB but can cause a range of other respiratory illnesses, including lung infections, pneumonia, and bronchitis. The simultaneous detection of Mycobacterium tuberculosis (TB) and Nontuberculous mycobacteria (NTM) is important because both types of mycobacteria can cause respiratory illnesses with similar symptoms, but require different treatment approaches. SMARTCHEK^® MTB/NTM Detection Kit is a real-time polymerase chain reaction assay designed for the simultaneous detection of MTB and NTM.